PAVmed Inc.（PAVM）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · PAVM · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$0.07M	$3.00M	$2.45M	$0.38M	$0.50M
Cost of Revenue	$0.32M	$6.04M	$6.42M	$3.61M	$0.58M
Gross Profit	($0.25M)	($3.04M)	($3.97M)	($3.24M)	($0.09M)
Gross Margin %(computed)	-354.93%	-101.60%	-161.83%	-858.62%	-17.00%
Operating Expenses
R&D Expenses	$4492.00M	$5.93M	$14.28M	$25.34M	$19.85M
G&A Expenses	$16250.00M	$24.52M	$30.95M	$41.41M	$25.57M
Total Operating Expenses	$21.55M	$41.44M	$64.83M	$87.85M	$54.31M
Operating Income	($21.81M)	($44.49M)	($68.80M)	($91.09M)	($54.39M)
Operating Margin %(computed)	—	—	—	—	—
Interest Income	$0.03M	$0.25M	$0.51M	$0.17M	$0.00M
Interest Expense	$0.02M	$0.04M	$0.59M	$1.28M	$0.00M
Income Before Tax	($2.47M)	$28.43M	($79.26M)	($103.24M)	($56.13M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	$0.40M	$39.79M	($64.17M)	($88.98M)	($50.35M)
Net Margin %(computed)	564.79%	—	—	—	—
Per Share & EBITDA
EPS (Basic)	$-5.63	$99.15	$-274.92	$-450.95	$-293.92
Wtd Avg Shares	0.67M	0.32M	0.24M	0.20M	0.17M
EBITDA	($21.70M)	$29.67M	($75.74M)	($99.50M)	($55.90M)
EBITDA Margin %(computed)	—	990.65%	—	—	—